EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.6 | (-)-epigallocatechin-3-O-gallate | - |
Homo sapiens | |
2.1.1.6 | (2R,3R)-5,7-bis(acetyloxy)-2-[3,4,5-tris(acetyloxy)phenyl]-3,4-dihydro-2H-chromen-3-yl 3,4-bis(acetyloxy)-5-(2-oxopropyl)benzoate | - |
Homo sapiens | |
2.1.1.6 | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,4,5-trihydroxybenzoate) | - |
Homo sapiens | |
2.1.1.6 | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,5-dihydroxybenzoate) | - |
Homo sapiens | |
2.1.1.6 | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis[3,4,5-tris(acetyloxy)benzoate] | - |
Homo sapiens | |
2.1.1.6 | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis[3,5-bis(acetyloxy)benzoate] | - |
Homo sapiens | |
2.1.1.6 | additional information | (-)-epigallocatechin is not active even at a concentration of 0.05 mM | Homo sapiens | |
3.4.25.1 | (-)-epigallocatechin-3-gallate | i.e. EGCG, inhibits the proteasomal chymotrypsin-like activity | Homo sapiens | |
3.4.25.1 | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,4,5-triethoxybenzoate) | inhibits 48% of MDA-MB-231 cell proliferation at 0.05 mM | Homo sapiens | |
3.4.25.1 | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,4,5-trihydroxybenzoate) | - |
Homo sapiens | |
3.4.25.1 | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,5-diethoxybenzoate) | 70-79% inhibition in MDA-MB-231 cells at 0.025-0.050 mM | Homo sapiens | |
3.4.25.1 | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,5-dihydroxybenzoate) | - |
Homo sapiens | |
3.4.25.1 | additional information | inhibition of purified 20S proteasome and 26S proteasome activities by epigallocatechin-3-gallate and its analogues, overview | Homo sapiens | |
3.4.25.1 | pro-epigallocatechin-3-gallate | i.e. pro-EGCG, inhibitory efficacy is greatly improved from 42% inhibition to 89% inhibition when combined with 3,5-dinitrocatechol | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.6 | Homo sapiens | - |
- |
- |
3.4.25.1 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.6 | breast cancer cell | - |
Homo sapiens | - |
2.1.1.6 | MDA-MB-231 cell | - |
Homo sapiens | - |
3.4.25.1 | MDA-MB-231 cell | breast cancer cell | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.6 | (-)-epigallocatechin-3-O-gallate + S-adenosyl-L-methionine | - |
Homo sapiens | S-adenosyl-L-homocysteine + ? | - |
? | |
3.4.25.1 | N-succinyl-LLVY-7-amido-4-methylcoumarin + H2O | chymotrypsin-like proteasome activity | Homo sapiens | N-succinyl-LLVY + 7-amino-4-methylcoumarin | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.6 | COMT | - |
Homo sapiens |
3.4.25.1 | 20S proteasome | - |
Homo sapiens |
3.4.25.1 | proteasome | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.4.25.1 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.4.25.1 | 7.5 | - |
assay at | Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.1.1.6 | 0.029 | - |
70-79% inhibition at 0.025-0.05 mM | Homo sapiens | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,5-dihydroxybenzoate) | |
3.4.25.1 | 0.000086 | 0.000194 | inhibition of the chymotrypsin-like activity of the proteasome in vitro, pH not specified in the publication, temperature not specified in the publication | Homo sapiens | (-)-epigallocatechin-3-gallate | |
3.4.25.1 | 0.019 | - |
for the chymotrypsin-like activity, pH 7.5, 37°C | Homo sapiens | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,4,5-trihydroxybenzoate) | |
3.4.25.1 | 0.029 | - |
for the chymotrypsin-like activity, pH 7.5, 37°C | Homo sapiens | (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diyl bis(3,5-dihydroxybenzoate) |